Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: A 24-week, open-label, prospective study in Chinese population

Authors
Category Primary study
JournalNeuropsychiatric Disease and Treatment
Year 2017
This article has no abstract
Epistemonikos ID: 34a46b6875fd56de6480000117854a8f803a393d
First added on: Feb 08, 2025